<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="dd664f68-f5a3-4bb0-89d6-710318080179"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>BENZONATATE CAPSULES USP, 100 mg and 200 mg</title>
   <effectiveTime value="20250204"/>
   <setId root="3c4d1224-68c6-40c7-93c1-ff70f228242c"/>
   <versionNumber value="101"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="171714327" root="1.3.6.1.4.1.519.1"/>
            <name>Bryant Ranch Prepack</name>
            <assignedEntity>
               <assignedOrganization>
                  <id extension="171714327" root="1.3.6.1.4.1.519.1"/>
                  <name>Bryant Ranch Prepack</name>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="171714327" root="1.3.6.1.4.1.519.1"/>
                        <name>Bryant Ranch Prepack</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C73606" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="REPACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code codeSystem="2.16.840.1.113883.6.69" code="72162-1914"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C73607" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="RELABEL"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code codeSystem="2.16.840.1.113883.6.69" code="72162-1914"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="3699b2b9-f041-4604-bda9-bf8a3c7eb46e"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20241216"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="72162-1914" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Benzonatate</name>
                        <formCode code="C25158" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Benzonatate</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asEquivalentEntity classCode="EQUIV">
                           <code code="C64637" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <definingMaterialKind>
                              <code code="69452-144" codeSystem="2.16.840.1.113883.6.69"/>
                           </definingMaterialKind>
                        </asEquivalentEntity>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="35SW5USQ3G" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>D&amp;C YELLOW NO. 10</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="2G86QN327L" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GELATIN, UNSPECIFIED</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="PDC6A3C0OX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GLYCERIN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="200"/>
                              <denominator unit="1" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="5P4DHS6ENR" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BENZONATATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5P4DHS6ENR" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>BENZONATATE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="100" unit="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="72162-1914-1" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="20160815"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA081297" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20160815"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value code="C48330" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="yellow" xsi:type="CE"/>
                        </characteristic>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value value="1" xsi:type="INT"/>
                        </characteristic>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value code="C48345" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OVAL" xsi:type="CE">
                              <originalText>CAPSULE</originalText>
                           </value>
                        </characteristic>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value unit="mm" value="9" xsi:type="PQ"/>
                        </characteristic>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value xsi:type="ST">PA83</value>
                        </characteristic>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <component>
                  <observationMedia ID="L0f17c7c2-a154-4ade-b162-b82206a3b6e2">
                     <text>Structural Formula</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image001.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_section_id_86949b40-966d-4246-8bc7-543b3a86454a">
               <id root="8dfe41fe-548f-46ae-a7b6-29d613103aee"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_description_id_46db0056-f440-4ff6-8cb6-54e3ea6889f0">
               <id root="41fbba61-e440-423f-a6e1-36bd2d2ca848"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Benzonatate, a non-narcotic oral antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl
 
  <content styleCode="italics">p</content>(butylamino) benzoate; with a molecular weight of 603.7.

 </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="L0f17c7c2-a154-4ade-b162-b82206a3b6e2"/>
                  </paragraph>
                  <paragraph>Each soft gelatin capsule, for oral administration, contains 100 mg or 200 mg benzonatate USP. In addition, each capsule contains the following inactive ingredients: D&amp;C Yellow No. 10, gelatin, glycerin, and purified water.</paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_clinical_pharmacology_id_a8db545d-378c-45df-8157-79c2015b6c92">
               <id root="b39d87ee-42d8-4712-b2f5-108c63896555"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>BENZONATATE acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough reflex at its source. It begins to act within 15 to 20 minutes and its effect lasts for 3 to 8 hours. BENZONATATE has no inhibitory effect on the respiratory center in recommended dosage.</paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_indications_id_b0aa5d59-a127-4a67-aeff-d4c4ac42a17e">
               <id root="86667779-6d3a-42e1-8b73-caab5bdf8421"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>BENZONATATE is indicated for the symptomatic relief of cough.</paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_contraindications_id_bf09b678-4658-40de-97d5-560c8ac387ee">
               <id root="321d9698-4434-4e72-b6e8-d2a14f29d01f"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>Hypersensitivity to benzonatate or related compounds.</paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_warnings_id_3567cafe-2808-48bc-8861-44ad18bdc7ae">
               <id root="2cf3bdb6-547b-4173-83d2-c5d7579fb074"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <effectiveTime value="20160813"/>
               <component>
                  <section ID="i4i_section_id_96b81c76-7b70-4721-ab0e-d055b43ecbe7">
                     <id root="d9e78454-7971-4bb5-93b9-40fe52835c68"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>
                        <content styleCode="underline">Hypersensitivity</content>
                     </title>
                     <text>
                        <paragraph>Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures.</paragraph>
                     </text>
                     <effectiveTime value="20160813"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_section_id_6ed9690b-5616-4b67-975a-b384a1e2d6e6">
                     <id root="ed3569e8-38fc-43fc-8e05-447c38ee2897"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>
                        <content styleCode="underline">Psychiatric Effects</content>
                     </title>
                     <text>
                        <paragraph>Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking BENZONATATE in combination with other prescribed drugs.</paragraph>
                     </text>
                     <effectiveTime value="20160813"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_section_id_7aeaea77-2076-4199-bf6a-5245cbe0fac4">
                     <id root="4f8f66d3-ea16-4fdb-852b-d8feeafec885"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Accidental Ingestion and Death in Children</title>
                     <text>
                        <paragraph>Keep BENZONATATE out of reach of children. Accidental ingestion of BENZONATATE resulting in death has been reported in children below age 10. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. If accidental ingestion occurs, seek medical attention immediately (see OVERDOSAGE).</paragraph>
                     </text>
                     <effectiveTime value="20160813"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_precautions_id_35966ca6-10fb-4f21-b75a-ecb3ed9653d1">
               <id root="c71b3a1b-959c-415c-978b-a074189cfc19"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <text>
                  <paragraph>Benzonatate is chemically related to anesthetic agents of the para-amino-benzoic acid class (e.g. procaine; tetracaine) and has been associated with adverse CNS effects possibly related to a prior sensitivity to related agents or interaction with concomitant medication.</paragraph>
               </text>
               <effectiveTime value="20160813"/>
               <component>
                  <section ID="i4i_info_patients_id_e977a885-2a7c-4aaa-995b-62b2da07b66f">
                     <id root="682640a3-3a91-42a1-aeb7-2a24e45643a6"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>Information for patients:</title>
                     <text>
                        <paragraph>Swallow BENZONATATE Capsules whole. Do not break, chew, dissolve, cut, or crush BENZONATATE capsules. Release of BENZONATATE from the capsule in the mouth can produce a temporary local anesthesia of the oral mucosa and choking could occur. If numbness or tingling of the tongue, mouth, throat, or face occurs, refrain from oral ingestion of food or liquids until the numbness has resolved. If the symptoms worsen or persist, seek medical attention.</paragraph>
                        <paragraph>Keep BENZONATATE out of reach of children. Accidental ingestion resulting in death has been reported in children. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. Signs and symptoms may include restlessness, tremors, convulsions, coma and cardiac arrest. If accidental ingestion occurs, seek medical attention immediately.</paragraph>
                        <paragraph>Overdosage resulting in death may occur in adults.</paragraph>
                        <paragraph>Do not exceed a single dose of 200 mg and a total daily dosage of 600 mg. If you miss a dose of BENZONATATE, skip that dose and take the next dose at the next scheduled time. Do not take 2 doses of BENZONATATE at one time.</paragraph>
                     </text>
                     <effectiveTime value="20160813"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_pregnancy_id_91c1d0f2-7bf1-4062-bc73-0afd346f2027">
                     <id root="411d6f81-28d9-4ef6-96c9-004fc5dcbae0"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>Usage in Pregnancy:</title>
                     <effectiveTime value="20160813"/>
                     <component>
                        <section ID="i4i_pregnancy_C_id_222856b6-823a-462c-9884-e09c4e246deb">
                           <id root="7476e165-98f5-4c75-b03c-4d6720c95891"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>Pregnancy Category C.</title>
                           <text>
                              <paragraph>Animal reproduction studies have not been conducted with BENZONATATE. It is also not known whether BENZONATATE can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. BENZONATATE should be given to a pregnant woman only if clearly needed.</paragraph>
                           </text>
                           <effectiveTime value="20160813"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="i4i_nursing_mothers_id_9440a947-e64d-4bcc-972b-9d6aa132f626">
                     <id root="b478a05b-2657-49ed-a02c-f238a31c6d0d"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>Nursing mothers:</title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk caution should be exercised when BENZONATATE is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20160813"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_carcinogenesis_mutagenesis_fertility_id_8c7056a2-a737-42b8-bdf8-88f5e1cc977e">
                     <id root="5639addd-75a3-4014-b136-52aa68196407"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis, mutagenesis, impairment of fertility:</title>
                     <text>
                        <paragraph>Carcinogenicity, mutagenicity, and reproduction studies have not been conducted with BENZONATATE.</paragraph>
                     </text>
                     <effectiveTime value="20160813"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_pediatric_use_id_6f155959-7342-4195-87ec-f9a34787028c">
                     <id root="6e674975-883b-4fc2-8573-a2dfcb7916d1"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric Use:</title>
                     <text>
                        <paragraph>Safety and effectiveness in children below the age of 10 have not been established. Accidental ingestion resulting in death has been reported in children below age 10. Keep out of reach of children.</paragraph>
                     </text>
                     <effectiveTime value="20160813"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_adverse_effects_id_6c528a36-ad31-42af-b245-3b6d063d73f9">
               <id root="723c36ec-1c03-48be-ad54-97c3d8f218e3"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>Potential Adverse Reactions to BENZONATATE may include:</paragraph>
                  <paragraph>
                     <content styleCode="bold">Hypersensitivity reactions</content>including bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">CNS:</content>sedation; headache; dizziness; mental confusion; visual hallucinations.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">GI:</content>constipation; nausea; GI upset.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dermatologic:</content>pruritus; skin eruptions.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">Other:</content>nasal congestion; sensation of burning in the eyes; vague "chilly" sensation; numbness of the chest; hypersensitivity.

 </paragraph>
                  <paragraph>Deliberate or accidental overdose has resulted in death, particularly in children.</paragraph>
                  <paragraph>To report SUSPECTED ADVERSE REACTIONS, contact Bionpharma at 1-888-235-2466 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch</paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_overdosage_id_c2b7d01f-d1be-4ff3-89b9-aec8bec68b69">
               <id root="96823b9b-9fa0-4561-9419-5e77d7876e3c"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>OVERDOSAGE</title>
               <text>
                  <paragraph>Intentional and unintentional overdose may result in death, particularly in children.</paragraph>
                  <paragraph>The drug is chemically related to tetracaine and other topical anesthetics and shares various aspects of their pharmacology and toxicology. Drugs of this type are generally well absorbed after ingestion.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Signs and Symptoms:</content>
                  </paragraph>
                  <paragraph>The signs and symptoms of overdose of benzonatate have been reported within 15-20 minutes. If capsules are chewed or dissolved in the mouth, oropharyngeal anesthesia will develop rapidly, which may cause choking and airway compromise.</paragraph>
                  <paragraph>CNS stimulation may cause restlessness and tremors which may proceed to clonic convulsions followed by profound CNS depression. Convulsions, coma, cerebral edema and cardiac arrest leading to death have been reported within 1 hour of ingestion.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Treatment:</content>
                  </paragraph>
                  <paragraph>In case of overdose, seek medical attention immediately. Evacuate gastric contents and administer copious amounts of activated charcoal slurry. Even in the conscious patient, cough and gag reflexes may be so depressed as to necessitate special attention to protection against aspiration of gastric contents and orally administered materials. Convulsions should be treated with a short-acting barbiturate given intravenously and carefully titrated for the smallest effective dosage. Intensive support of respiration and cardiovascular-renal function is an essential feature of the treatment of severe intoxication from overdosage.</paragraph>
                  <paragraph>Do not use CNS stimulants.</paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_dosage_admin_id_85b0c523-ecec-4857-8eca-0e1f3d64df65">
               <id root="3676ee80-7fb2-41f7-a4c3-f64189deec2d"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>Adults and Children over 10 years of age: Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given.
 
  <content styleCode="bold">BENZONATATE should be swallowed whole.</content>BENZONATATE Capsules are not to be broken, chewed, dissolved, cut or crushed.

 </paragraph>
               </text>
               <effectiveTime value="20160813"/>
            </section>
         </component>
         <component>
            <section ID="i4i_how_supplied_id_fdc51f95-50f8-4023-b94d-c96e613d3516">
               <id root="c787b5ff-b02c-415f-9fcc-76b3f657547a"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Benzonatate Capsules USP, 200 mg: Yellow soft gelatin capsules, imprinted with "PA83", available in bottles of 100's (NDC 72162-1914-1)</paragraph>
                  <paragraph>The capsules should be protected from light, moisture and humidity, and stored at controlled room temperature 20° to 25°C (68° to 77°F) [See USP].</paragraph>
                  <paragraph>Dispense in a tight, light-resistant container as defined in USP/NF.</paragraph>
                  <paragraph>Repackaged/Relabeled by:<br/>Bryant Ranch Prepack, Inc.<br/>Burbank, CA 91504</paragraph>
               </text>
               <effectiveTime value="20250306"/>
            </section>
         </component>
         <component>
            <section>
               <id root="83576935-4fb6-4648-bd89-3cdd1f4db314"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Benzonatate 200 mg Capsule</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="mm63629"/>
               </text>
               <effectiveTime value="20250306"/>
               <component>
                  <observationMedia ID="mm63629">
                     <text>Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="lbl721621914.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>